Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics to Reduce Antepartum Group B Streptococcus Colonization
NCT03696953Phase 2Active, not recruiting
- Sponsor
- Marquette University
- Start
- Feb 2019
- Primary completion
- Sep 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of bifidobacterium + lactobacillus in Streptococcus agalactiae colonization, sponsored by Marquette University. Started Feb 2019; status: active, not recruiting.
02
Drugs
bifidobacterium + lactobacillus
03
Conditions
Streptococcus agalactiae colonization
Beyond the preview
Go deeper on NCT03696953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03696953.